There is lots of talk about the discontinuation of Daybue. And there are a lot of nervous shareholders out there... just relax, Culper is a nothing /nobody. The only asset they have at their disposal is fear, which is a bottom feeder way to run a business. It's a 1 person business and it's clear they he not good at what he does.
The fact remains discontinuation of Daybue is significantly better than clinical trials.
Diarrhea and GI is the biggest problem, it would be amazing if this could be addressed by Arcadia... and they are trying!!
Arcadia are working on a new formulation which is not in a liquid form (freeze dried or similar).. it is hoped that this will address the GI issues, which we could all expect to improve discontinuation and maybe allow some who had had to discontinue to restart Daybue.
The good news is that it will likely not require a new trial, just bioequivalence data.
(20min delay)